Samsung Heir, Seeking to Remake Family Legacy, Instead Faces Scandal
BrainScope Announces Publication Demonstrating Extremely High Accuracy of the Ahead 300 for Identification of Traumatic Brain Injury in a Large Prospective Validation Study
Western Equine Encephalitis - Pipeline Review, H2 2016 - Key Players are Akshaya Bio, Altravax, EpiVax, H&P Labs & Profectus BioSciences - Research and Markets
When Bill Buechler slipped into a coma , little did he know he'd emerge from his experience with the best firm ever.
Some readers favor the flexibility of a sprawling portfolio, while others prefer a simpler approach.
This article represents opinions of the author and not those of his firm and are subject to change from time to time and do not constitute a recommendation to purchase and sale any security nor to engage in any particular investment strategy. The information contained here has been obtained from ...
Novel products will allow drug firms to achieve price premiums on diabetes drugs in the U.S. and at least retain level pricing internationally.
Don't wait too long to address these crucial issues.